Product Code: SR112023A6523
Abstract
Market Overview:
The global telemedicine market size reached US$ 59.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 218.0 Billion by 2028, exhibiting a growth rate (CAGR) of 21.9% during 2023-2028.
Telemedicine is the remote delivery of healthcare services, such as consultations or assessments, via telephone networks without the requirement for an in-person visit. There are several components to a telemedicine system, such as hardware, software, and a communication channel, that allow information to be exchanged between two geographical locations. Using telecommunication infrastructures, remote delivery of healthcare services can be performed efficiently. In addition to this, follow-up visits, management of chronic conditions, medication management, and specialist consultations can also be managed via text, audio and video conferences. Remote access to physicians not only makes it easier for patients to connect with them, but it can also help reduce overall healthcare costs. As a result, medical practitioners and hospitals alike are looking forward to implementing digital health technologies in their practices.
Telemedicine Market Trends:
The market is majorly driven by the rapid digitization in the medical sector across the globe. This can be attributed to continual technological advancements for making healthcare affordable and accessible to the masses. In addition to this, the integration of advanced technologies, such as machine learning (ML), artificial intelligence (AI), and the Internet of Things (IoT), is resulting in a higher product uptake on the global level. The proliferation of e-visits, along with the rapid expansion of radiology, cardiology, and mental health segments, is resulting in the development of new business and healthcare models, thereby propelling the market. Apart from this, the rising prevalence of chronic diseases, including diabetes and cancer, as well as a lack of adequate healthcare services in underdeveloped regions, is increasing the demand for telemedicine across the globe. Some of the other factors contributing to the market include continuous postponement and cancellation of elective surgeries and appointments due to social distancing norms during COVID-19, fierce market competition among key players, the launch of numerous innovative products, such as smart medicine cabinets, and extensive research and development (R&D) activities.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global telemedicine market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on component, modality, delivery mode, facility, application and end user.
Breakup by Component:
Product
Hardware
Software
Others
Services
Tele-consulting
Tele-monitoring
Tele-education
Breakup by Modality:
Real-time
Store and Forward
Others
Breakup by Delivery Mode:
Web/Mobile
Audio/Text-based
Visualized
Call Centers
Breakup by Facility:
Tele-hospital
Tele-home
Breakup by Application:
Teledermatology
Teleradiology
Telepsychiatry
Telepathology
Telecardiology
Others
Breakup by End User:
Providers
Payers
Patients
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Aerotel Medical Systems (1998) Ltd., Allscripts Healthcare Solutions Inc., AMD Global Telemedicine Inc., American Well Corporation, Cigna Corporation, Cisco Systems Inc., Doxy.me Inc., HealthTap Inc., PlushCare Inc. (Accolade Inc.), SHL Telemedicine, SOC Telemed Inc. (Patient Square Capital), Teladoc Health Inc. and Twilio Inc.
Key Questions Answered in This Report
- 1. What was the size of the global telemedicine market in 2022?
- 2. What is the expected growth rate of the global telemedicine market during 2023-2028?
- 3. What are the key factors driving the global telemedicine market?
- 4. What has been the impact of COVID-19 on the global telemedicine market?
- 5. What is the breakup of the global telemedicine market based on the component?
- 6. What is the breakup of the global telemedicine market based on the modality?
- 7. What is the breakup of the global telemedicine market based on delivery mode?
- 8. What is the breakup of the global telemedicine market based on the facility?
- 9. What is the breakup of the global telemedicine market based on the application?
- 10. What are the key regions in the global telemedicine market?
- 11. Who are the key players/companies in the global telemedicine market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Telemedicine Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Component
- 6.1 Product
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Hardware
- 6.1.2.2 Software
- 6.1.2.3 Others
- 6.1.3 Market Forecast
- 6.2 Services
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Tele-consulting
- 6.2.2.2 Tele-monitoring
- 6.2.2.3 Tele-education
- 6.2.3 Market Forecast
7 Market Breakup by Modality
- 7.1 Real-time
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Store and Forward
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Others
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Delivery Mode
- 8.1 Web/Mobile
- 8.1.1 Market Trends
- 8.1.2 Key Segments
- 8.1.2.1 Audio/Text-based
- 8.1.2.2 Visualized
- 8.1.3 Market Forecast
- 8.2 Call Centers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by Facility
- 9.1 Tele-hospital
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Tele-home
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
10 Market Breakup by Application
- 10.1 Teledermatology
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 Teleradiology
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
- 10.3 Telepsychiatry
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
- 10.4 Telepathology
- 10.4.1 Market Trends
- 10.4.2 Market Forecast
- 10.5 Telecardiology
- 10.5.1 Market Trends
- 10.5.2 Market Forecast
- 10.6 Others
- 10.6.1 Market Trends
- 10.6.2 Market Forecast
11 Market Breakup by End User
- 11.1 Providers
- 11.1.1 Market Trends
- 11.1.2 Market Forecast
- 11.2 Payers
- 11.2.1 Market Trends
- 11.2.2 Market Forecast
- 11.3 Patients
- 11.3.1 Market Trends
- 11.3.2 Market Forecast
- 11.4 Others
- 11.4.1 Market Trends
- 11.4.2 Market Forecast
12 Market Breakup by Region
- 12.1 North America
- 12.1.1 United States
- 12.1.1.1 Market Trends
- 12.1.1.2 Market Forecast
- 12.1.2 Canada
- 12.1.2.1 Market Trends
- 12.1.2.2 Market Forecast
- 12.2 Asia-Pacific
- 12.2.1 China
- 12.2.1.1 Market Trends
- 12.2.1.2 Market Forecast
- 12.2.2 Japan
- 12.2.2.1 Market Trends
- 12.2.2.2 Market Forecast
- 12.2.3 India
- 12.2.3.1 Market Trends
- 12.2.3.2 Market Forecast
- 12.2.4 South Korea
- 12.2.4.1 Market Trends
- 12.2.4.2 Market Forecast
- 12.2.5 Australia
- 12.2.5.1 Market Trends
- 12.2.5.2 Market Forecast
- 12.2.6 Indonesia
- 12.2.6.1 Market Trends
- 12.2.6.2 Market Forecast
- 12.2.7 Others
- 12.2.7.1 Market Trends
- 12.2.7.2 Market Forecast
- 12.3 Europe
- 12.3.1 Germany
- 12.3.1.1 Market Trends
- 12.3.1.2 Market Forecast
- 12.3.2 France
- 12.3.2.1 Market Trends
- 12.3.2.2 Market Forecast
- 12.3.3 United Kingdom
- 12.3.3.1 Market Trends
- 12.3.3.2 Market Forecast
- 12.3.4 Italy
- 12.3.4.1 Market Trends
- 12.3.4.2 Market Forecast
- 12.3.5 Spain
- 12.3.5.1 Market Trends
- 12.3.5.2 Market Forecast
- 12.3.6 Russia
- 12.3.6.1 Market Trends
- 12.3.6.2 Market Forecast
- 12.3.7 Others
- 12.3.7.1 Market Trends
- 12.3.7.2 Market Forecast
- 12.4 Latin America
- 12.4.1 Brazil
- 12.4.1.1 Market Trends
- 12.4.1.2 Market Forecast
- 12.4.2 Mexico
- 12.4.2.1 Market Trends
- 12.4.2.2 Market Forecast
- 12.4.3 Others
- 12.4.3.1 Market Trends
- 12.4.3.2 Market Forecast
- 12.5 Middle East and Africa
- 12.5.1 Market Trends
- 12.5.2 Market Breakup by Country
- 12.5.3 Market Forecast
13 SWOT Analysis
- 13.1 Overview
- 13.2 Strengths
- 13.3 Weaknesses
- 13.4 Opportunities
- 13.5 Threats
14 Value Chain Analysis
15 Porters Five Forces Analysis
- 15.1 Overview
- 15.2 Bargaining Power of Buyers
- 15.3 Bargaining Power of Suppliers
- 15.4 Degree of Competition
- 15.5 Threat of New Entrants
- 15.6 Threat of Substitutes
16 Price Analysis
17 Competitive Landscape
- 17.1 Market Structure
- 17.2 Key Players
- 17.3 Profiles of Key Players
- 17.3.1 Aerotel Medical Systems (1998) Ltd.
- 17.3.1.1 Company Overview
- 17.3.1.2 Product Portfolio
- 17.3.2 Allscripts Healthcare Solutions Inc.
- 17.3.2.1 Company Overview
- 17.3.2.2 Product Portfolio
- 17.3.2.3 Financials
- 17.3.2.4 SWOT Analysis
- 17.3.3 AMD Global Telemedicine Inc.
- 17.3.3.1 Company Overview
- 17.3.3.2 Product Portfolio
- 17.3.4 American Well Corporation
- 17.3.4.1 Company Overview
- 17.3.4.2 Product Portfolio
- 17.3.4.3 Financials
- 17.3.5 Cigna Corporation
- 17.3.5.1 Company Overview
- 17.3.5.2 Product Portfolio
- 17.3.5.3 Financials
- 17.3.5.4 SWOT Analysis
- 17.3.6 Cisco Systems Inc.
- 17.3.6.1 Company Overview
- 17.3.6.2 Product Portfolio
- 17.3.6.3 Financials
- 17.3.6.4 SWOT Analysis
- 17.3.7 Doxy.me Inc.
- 17.3.7.1 Company Overview
- 17.3.7.2 Product Portfolio
- 17.3.8 HealthTap Inc.
- 17.3.8.1 Company Overview
- 17.3.8.2 Product Portfolio
- 17.3.9 PlushCare Inc. (Accolade Inc.)
- 17.3.9.1 Company Overview
- 17.3.9.2 Product Portfolio
- 17.3.10 SHL Telemedicine
- 17.3.10.1 Company Overview
- 17.3.10.2 Product Portfolio
- 17.3.11 SOC Telemed Inc. (Patient Square Capital)
- 17.3.11.1 Company Overview
- 17.3.11.2 Product Portfolio
- 17.3.12 Teladoc Health Inc.
- 17.3.12.1 Company Overview
- 17.3.12.2 Product Portfolio
- 17.3.12.3 Financials
- 17.3.13 Twilio Inc.
- 17.3.13.1 Company Overview
- 17.3.13.2 Product Portfolio
- 17.3.13.3 Financials
- 17.3.13.4 SWOT Analysis